v3.26.1
Promissory Note - Additional Information (Details)
$ / shares in Units, shares in Millions
3 Months Ended 6 Months Ended
Jun. 23, 2026
USD ($)
$ / shares
shares
Feb. 28, 2025
USD ($)
$ / shares
Jun. 30, 2026
USD ($)
$ / shares
Jun. 30, 2026
USD ($)
$ / shares
Jun. 30, 2025
USD ($)
Feb. 27, 2025
$ / shares
Debt Instrument [Line Items]            
Timing of milestone       Dec. 31, 2025    
Term loan $ 10,000,000          
Debt instrument convertible BSOPM percentage       100.00%    
Maturity date   Sep. 01, 2028        
Fair Value Adjustment of Promissory Notes       $ (500,000) $ (423,000)  
Promissory note     $ 9,200,000 $ 9,200,000    
Pre Funded Warrants            
Debt Instrument [Line Items]            
Exercise price of warrants per share | $ / shares     $ 0.0001 $ 0.0001    
Calibrated Discount Rate            
Debt Instrument [Line Items]            
Debt Instrument, Measurement Input     0.137 0.137    
Scenario Weighting for Repayment through Maturity            
Debt Instrument [Line Items]            
Debt Instrument, Measurement Input     0.80 0.80    
Scenario Weighting for Repayment through Milestone            
Debt Instrument [Line Items]            
Debt Instrument, Measurement Input     0.20 0.20    
Loan Agreement            
Debt Instrument [Line Items]            
Aggregate principal amount   $ 32,500,000        
Debt Instrument, Interest Rate, Stated Percentage   12.75%        
Increased final payement fee $ 200,000          
Debt conversion price | $ / shares $ 1          
Exercise price of warrants per share | $ / shares $ 1 $ 1       $ 2.32
Description on the conversion of debt       the Lender's existing right to convert up to $1.0 million of outstanding principal into common stock was replaced with the right, at the Lender's option, to convert up to an aggregate of $3.0 million of outstanding principal into either shares of the Company's common stock or pre-funded warrants, at a conversion price of $1.00 per share (or $0.9999 per underlying share for pre-funded warrants, reflecting the $0.0001 exercise price)    
Warrants issued to purchase shares of common stock | shares 1          
Loan Agreement | Minimum [Member]            
Debt Instrument [Line Items]            
Maturity date Sep. 01, 2028          
Extended interest maturity date Sep. 30, 2026          
Loan Agreement | Maximum [Member]            
Debt Instrument [Line Items]            
Maturity date Sep. 01, 2029          
Extended interest maturity date Sep. 30, 2027          
Loan Agreement | Common Stock            
Debt Instrument [Line Items]            
Convertible Debt $ 1,000,000          
Share price | $ / shares $ 0.0001          
Loan Agreement | Pre Funded Warrants            
Debt Instrument [Line Items]            
Convertible Debt $ 3,000,000          
Share price | $ / shares $ 0.9999          
Loan Agreement | Prime Rate            
Debt Instrument [Line Items]            
Debt Instrument, Interest Rate, Stated Percentage   5.00%        
Loan Agreement | Lender And Collateral Agent            
Debt Instrument [Line Items]            
Convertible value of promissory note warrants into common stock   $ 1,000,000        
Debt instrument, convertible, terms of conversion       At the closing date, up to $1,000,000 of the principal outstanding may be converted into shares of the Company’s unrestricted, freely tradable common stock at a price equal to 20% premium to the exercise price of the warrants (see Note 6 for further description of the warrants) at the Lender’s option. In connection with the pause in enrollment in the KOURAGE trial, Tranche 2 and Tranche 3 are no longer available to the Company.    
Promissory note            
Debt Instrument [Line Items]            
Inital fair value     $ 8,900,000 $ 8,900,000    
Fair Value Adjustment of Promissory Notes     $ 2,500,000 $ 500,000    
Tranche 1 | Loan Agreement            
Debt Instrument [Line Items]            
Aggregate principal amount   10,000,000        
Tranche 2 | Loan Agreement            
Debt Instrument [Line Items]            
Aggregate principal amount   $ 7,500,000        
Repayment term   As for the initial term of the Loan before the loan amendment described below, the Company will make interest only payments until the 18 month anniversary of the Closing Date.        
Tranche 2 | Loan Agreement | Lender And Collateral Agent            
Debt Instrument [Line Items]            
Aggregate principal amount   $ 15,000,000